IL‐10 fails to abrogate experimental autoimmune encephalomyelitis

No abstract is available for this paper.

• Publication year

  1996

• Venue

  Journal of Neuroscience Research

• Publication date

  1996-09-15

• Fields of study

  Biology, Medicine

• Identifiers
  DOI 10.1002/(SICI)1097-4547(19960915)45:6<735::AID-JNR10>3.0.CO;2-VPMID 8892085
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• IL-4, IL-10 and IFN-gamma have distinct, but interacting, effects on differentiation-induced changes in TNF-alpha and TNF receptor release by cultured human monocytes.

  1996cited by this paper
• The adhesion molecule and cytokine profile of multiple sclerosis lesions

  1995cited by this paper
• Antigen presentation in the central nervous system. The inhibitory effect of IL-10 on MHC class II expression and production of cytokines depends on the inducing signals and the type of cell analyzed.

  1994cited by this paper
• Macrophage apoptosis in the central nervous system in experimental autoimmune encephalomyelitis.

  1994cited by this paper
• Interleukin‐10 prevents experimental allergic encephalomyelitis in rats

  1994cited by this paper
• Cytokine-induced immune deviation as a therapy for inflammatory autoimmune disease

  1994cited by this paper
• Role of gamma delta T cells in murine collagen-induced arthritis.

  1993cited by this paper
• Encephalitogenic Th1 cells are inhibited by Th2 cells with related peptide specificity: relative roles of interleukin (IL)-4 and IL-10.

  1993cited by this paper
• Apoptosis of T lymphocytes in experimental autoimmune encephalomyelitis. Evidence for programmed cell death as a mechanism to control inflammation in the brain.

  1993cited by this paper
• Monoclonal anti-gamma interferon antibodies enhance experimental allergic encephalomyelitis.

  1993cited by this paper
• Effect of anti-interferon-γ and anti-interleukin-2 monoclonal antibody treatment on the development of actively and passively induced experimental allergic encephalomyelitis in the SJL/J mouse

  1992cited by this paper
• IL-10 inhibits parasite killing and nitrogen oxide production by IFN-gamma-activated macrophages.

  1992cited by this paper
• Analysis of cytokine mRNA expression in the central nervous system of mice with experimental autoimmune encephalomyelitis reveals that IL-10 mRNA expression correlates with recovery.

  1992cited by this paper
• Interleukin-10 (IL-10) inhibits the induction of nitric oxide synthase by interferon-gamma in murine macrophages.

  1992cited by this paper
• Experimental autoimmune encephalomyelitis is exacerbated by IL-1 alpha and suppressed by soluble IL-1 receptor.

  1991cited by this paper
• Apoptosis in the nervous system in experimental allergic encephalomyelitis.

  1991cited by this paper
• Interleukin 10(IL-10) inhibits cytokine synthesis by human monocytes: an autoregulatory role of IL-10 produced by monocytes

  1991cited by this paper
• Macrophage deactivation by interleukin 10

  1991cited by this paper
• Anti—tumor necrosis factor therapy abrogates autoimmune demyelination

  1991cited by this paper
• IL-10 inhibits cytokine production by activated macrophages.

  1991cited by this paper
• Successful treatment of experimental allergic encephalomyelitis with transforming growth factor-beta 1.

  1991cited by this paper
• Prevention and treatment of chronic relapsing experimental allergic encephalomyelitis by transforming growth factor-beta 1.

  1991cited by this paper
• An antibody to lymphotoxin and tumor necrosis factor prevents transfer of experimental allergic encephalomyelitis

  1990cited by this paper
• Two types of mouse T helper cell. IV. Th2 clones secrete a factor that inhibits cytokine production by Th1 clones

  1989cited by this paper
• Enhancement of experimental allergic encephalomyelitis in mice by antibodies against IFN-gamma.

  1988cited by this paper
• Biology of disease. Analysis of autoimmune demyelination: its impact upon multiple sclerosis.

  1984cited by this paper
• Adoptive transfer of myelin basic protein-sensitized T cells produces chronic relapsing demyelinating disease in mice

  1984cited by this paper
• Adoptive transfer of experimental allergic encephalomyelitis in SJL/J mice after in vitro activation of lymph node cells by myelin basic protein: requirement for Lyt 1+ 2- T lymphocytes.

  1981cited by this paper
• Apoptosis: A Basic Biological Phenomenon with Wide-ranging Implications in Tissue Kinetics

  1972cited by this paper

• Interleukin-10 contrasts inflammatory synaptopathy and central neurodegenerative damage in multiple sclerosis

  2024cites this paper
• Programming tissue-sensing T cells that deliver therapies to the brain.

  2024cites this paper
• IL-37 suppresses CNS autoimmunity by increasing the frequency of Treg cells and reducing CD4 + T cell-derived IL-10 production

  2024cites this paper
• Under the influence: environmental factors as modulators of neuroinflammation through the IL-10/IL-10R axis

  2023cites this paper
• IL-10 Gene Polymorphisms and IL-10 Serum Levels in Patients with Multiple Sclerosis in Lithuania

  2022cites this paper
• Nanoformulated Recombinant Human Myelin Basic Protein and Rituximab Modulate Neuronal Perturbations in Experimental Autoimmune Encephalomyelitis in Mice

  2022cites this paper
• Astrocyte-targeted Overproduction of IL-10 Reduces Neurodegeneration after TBI

  2022cites this paper
• CD4+ T-cell-derived IL-10 promotes CNS inflammation in mice by sustaining effector T cell survival.

  2022cites this paper
• Single-cell secretion analysis reveals a dual role for IL-10 in restraining and resolving the TLR4-induced inflammatory response

  2020cites this paper
• Targeting IL-10 Family Cytokines for the Treatment of Human Diseases.

  2019cites this paper
• Lenalidomide regulates CNS autoimmunity by promoting M2 macrophages polarization

  2018cites this paper
• Repertoire in Naive Mice Homeostatic Regulation of the Autoreactive IL-10 Plays an Important Role in the

  2017cites this paper
• HYDROXYVITAMIN D AND CYTOKINES IN MULTIPLE SCLEROSIS

  2016cites this paper
• 25 Hydroxyvitamin D and Cytokines in Multiple Sclerosis

  2016cites this paper
• Endogenous adaptation to low oxygen modulates T-cell regulatory pathways in EAE

  2016cites this paper
• Seeking balance: Potentiation and inhibition of multiple sclerosis autoimmune responses by IL-6 and IL-10.

  2015cites this paper
• Interleukin-10 paradox: A potent immunoregulatory cytokine that has been difficult to harness for immunotherapy.

  2015cites this paper
• The therapeutic potential of interleukin-10 in neuroimmune diseases.

  2015cites this paper
• Alterations in microglial phenotype and hippocampal neuronal function in transgenic mice with astrocyte-targeted production of interleukin-10.

  2015cites this paper
• Increased Expression of Galectin-9 in Acute Experimental Autoimmune Encephalomyelitis

  2014cites this paper
• Subcutaneous inverse vaccination with PLGA particles loaded with a MOG peptide and IL-10 decreases the severity of experimental autoimmune encephalomyelitis.

  2014cites this paper
• This information is current as Presentation to Th1 Cells Secretion by Microglia During Antigen Required for IL-12 But Not Prostaglandin E2 Are γ CD40-CD154 Interaction and IFN-

  2013cites this paper
• Regulation of Adaptive Immunity; The Role of Interleukin-10

  2013cites this paper
• Health Sciences Research Commons

  2013cites this paper
• Relapses of Experimental Autoimmune Superantigen-Induced and Spontaneous Antibodies Against IL-12 Prevent

  2013cites this paper
• Human adipose-derived mesenchymal stem cells engineered to secrete IL-10 inhibit APC function and limit CNS autoimmunity.

  2013cites this paper
• This information is current as Central Nervous System Autoimmunity Dynamics and Paradoxically Promotes The T Cell Response to IL-10 Alters Cellular

  2012cites this paper
• Therapeutic Approaches in Multiple Sclerosis

  2012cites this paper
• Age-related accumulation of T cells with markers of relatively stronger autoreactivity leads to functional erosion of T cells

  2012cites this paper
• Does helminth activation of toll-like receptors modulate immune response in multiple sclerosis patients?

  2012cites this paper
• Regulatory role of resveratrol on Th17 in autoimmune disease.

  2011cites this paper
• Neuroprotection antiinflammatoire et antiischémique par modulation du protéasome

  2010cites this paper
• Cytokine networks in multiple sclerosis: lost in translation

  2010cites this paper
• TGF-β Enhances Effector Th1 Cell Activation but Promotes Self-Regulation via IL-10

  2010cites this paper
• IL-10-differentiated dendritic cells treatment for Experimental Autoimmune Encephalomyelitis (EAE), a model of human Multiple Sclerosis

  2010cites this paper
• Interleukin-10 Overexpression Promotes Fas-Ligand-Dependent Chronic Macrophage-Mediated Demyelinating Polyneuropathy

  2009cites this paper
• IL-10 mediated immunological tolerance: preclinical and clinical studies

  2009cites this paper
• VACCINE PLATFORM FOR INFECTION OR AUTOIMMUNE DISEASES USING AN ETEC FIMBRIAL SCAFFOLD

  2009cites this paper
• Strategies for use of IL‐10 or its antagonists in human disease

  2008cites this paper
• Exaggerated expression of skeletal muscle-derived interleukin-6, but not TNFalpha, in mice lacking interleukin-10.

  2008cites this paper
• Amelioration of experimental autoimmune encephalomyelitis in IL-4Ralpha-/- mice implicates compensatory up-regulation of Th2-type cytokines.

  2008cites this paper
• Cytokines in CNS Inflammation and Disease

  2008cites this paper
• IL-10 permits transient activation of dendritic cells to tolerize T cells and protect from central nervous system autoimmune disease.

  2007cites this paper
• Humanized Chimeric Receptors in the Therapy of Multiple Sclerosis

  2007cites this paper
• Cytokines and immune regulation in the nervous system

  2006cites this paper
• Oligodendrocyte cell death in pathogenesis of multiple sclerosis: Protection of oligodendrocytes from apoptosis by complement.

  2006cites this paper
• Altered neuroantigen-specific cytokine secretion in a Th2 environment reduces experimental autoimmune encephalomyelitis.

  2006cites this paper
• T Lymphocytes in EAE

  2005cites this paper
• The influence of sex hormones on cytokines in multiple sclerosis and experimental autoimmune encephalomyelitis: a review

  2005cites this paper
• Cytokines in multiple sclerosis: from bench to bedside.

  2005cites this paper
• A Live Diarrheal Vaccine Imprints a Th2 Cell Bias and Acts as an Anti-Inflammatory Vaccine1

  2005cites this paper
• Auto-immunity as Evolutionary by Product of Adoptive Immunity and Source of Anti-tumor Immunity Failure

  2005cites this paper
• Cytokines in Experimental Autoimmune Encephalomyelitis

  2005cites this paper
• Encephalitogenic and tolerogenic potential of altered peptide ligands of MOG and PLP in Biozzi ABH mice.

  2005cites this paper
• VaccineBias and Acts as an Anti-Inflammatory A Live Diarrheal Vaccine Imprints a Th2 Cell

  2005cites this paper
• Effect of Interleukin-10 on Newborn Piglet Brain following Hypoxia-Ischemia and Endotoxin-Induced Inflammation

  2005cites this paper
• Cytokine-Based Therapeutics for Intrinsic CNS Disease Processes

  2005cites this paper
• Th1 and Th2 lymphocytes in autoimmune disease.

  2005cites this paper
• IL-10 Plays an Important Role in the Homeostatic Regulation of the Autoreactive Repertoire in Naive Mice1

  2004cites this paper
• Immunotherapy for multiple sclerosis: basic insights for new clinical strategies.

  2004cites this paper
• Role of nerve growth factor and other trophic factors in brain inflammation.

  2004cites this paper
• IFN-Inducible Protein 10/CXC Chemokine Ligand 10-Independent Induction of Experimental Autoimmune Encephalomyelitis1

  2004cites this paper
• Theiler's Virus Infection: a Model for Multiple Sclerosis

  2004cites this paper
• Investigating the regulatory cells that mediate recovery from CNS-targeted autoimmune disease

  2004cites this paper
• Role of interferon‐γ and nitric oxide in the neuropathogenesis of avirulent Semliki Forest virus infection

  2003cites this paper
• Cytokines in the pathogenesis and therapy of autoimmune encephalomyelitis and multiple sclerosis.

  2003cites this paper
• Progression of autoimmune-mediated hepatic lesions in a murine graft-versus-host reaction by neutralizing IL-10.

  2003cites this paper
• Regional and temporal expression patterns of interleukin-10, interleukin-10 receptor and adhesion molecules in the rat spinal cord during chronic relapsing EAE.

  2003cites this paper
• Autoimmune Diseases as the Loss of Active “Self‐Control”

  2003cites this paper
• Tissue expression of inducible nitric oxide synthase requires IFN-gamma production by infiltrating splenic T cells: more evidence for immunosuppression by nitric oxide.

  2003cites this paper
• Expression of the Long Form of Human FLIP by Retroviral Gene Transfer of Hemopoietic Stem Cells Exacerbates Experimental Autoimmune Encephalomyelitis 1

  2003cites this paper
• Differential efficacy of a synthetic antagonist of VLA‐4 during the course of chronic relapsing experimental autoimmune encephalomyelitis

  2003cites this paper
• IL-10, a key effector regulatory cytokine in experimental autoimmune encephalomyelitis.

  2003cites this paper
• CHAPTER 25 – Interleukin-10

  2003cites this paper
• The Use of Cytokine Knockouts in Animal Models of Autoimmune Disease

  2003cites this paper
• Encephalomyelitis Experimental Autoimmune Ligand 10-Independent Induction of IFN-Inducible Protein 10 / CXC Chemokine and

  2003cites this paper
• The role of interleukin 10 in the control of autoimmunity.

  2003cites this paper
• This information is current as Autoimmune Encephalomyelitis Stem Cells Exacerbates Experimental by Retroviral Gene Transfer of Hemopoietic Expression of the Long Form of Human FLIP

  2003cites this paper
• Cytokine shifts and tolerance in experimental autoimmune encephalomyelitis

  2003cites this paper
• Articles 944 Results B Cell–deficient Mice Fail to Resolve Eae

  2002cites this paper
• Anti-Inflammatory Cytokines: Expression and Action in the Brain

  2002cites this paper
• Oral terbutaline differentially affects cytokine (IL-10, IL-12, TNF, IFNg) release in multiple sclerosis patients and controls.

  2002cites this paper
• Cellular localization and expression patterns of interleukin‐10, interleukin‐4, and their receptors in multiple sclerosis lesions

  2002cites this paper
• Intranasal peptide-induced peripheral tolerance: the role of IL-10 in regulatory T cell function within the context of experimental autoimmune encephalomyelitis.

  2002cites this paper
• Interferon-beta therapy for multiple sclerosis induces reciprocal changes in interleukin-12 and interleukin-10 production.

  2002cites this paper
• Type I Interferons Inhibit Interleukin-10 Production in Activated Human Monocytes and Stimulate IL-10 in T Cells: Implications for Th1-Mediated Diseases

  2002cites this paper
• IL-10-Deficient B10.Q Mice Develop More Severe Collagen-Induced Arthritis, but Are Protected from Arthritis Induced with Anti-Type II Collagen Antibodies

  2002cites this paper
• The role of interleukin-10 in autoimmune disease: systemic lupus erythematosus (SLE) and multiple sclerosis (MS).

  2002cites this paper
• B cells regulate autoimmunity by provision of IL-10

  2002cites this paper
• Effect of indoleamine 2,3-dioxygenase on induction of experimental autoimmune encephalomyelitis.

  2002cites this paper
• Therapeutic approaches in multiple sclerosis: lessons from failed and interrupted treatment trials.

  2002cites this paper
• Pathogenic and Regulatory Cytokines in Experimental Autoimmune Encephalomyelitis

  2002cites this paper
• Cytokines and Resistance to Organ Specific Autoimmune Disease

  2002cites this paper
• Prolonged reversal of chronic experimental allergic encephalomyelitis using a small molecule inhibitor of alpha4 integrin.

  2002cites this paper
• The germless theory of allergic disease: revisiting the hygiene hypothesis

  2001cites this paper
• Interleukin-10 in the brain.

  2001cites this paper
• Nitric oxide and T helper cell immunity.

  2001cites this paper
• Interleukin-10 and the interleukin-10 receptor.

  2001cites this paper
• Transgenic Expression of IL-10 in T Cells Facilitates Development of Experimental Myasthenia Gravis1

  2001cites this paper
• Interferon-beta in multiple sclerosis: altering the balance of interleukin-12 and interleukin-10?

  2001cites this paper